Literature DB >> 24371170

Analysis of regulatory networks constructed based on gene coexpression in pituitary adenoma.

Jie Gong1, Bo Diao, Guo Jie Yao, Ying Liu, Guo Zheng Xu.   

Abstract

Gene coexpression patterns can reveal gene collections with functional consistency. This study systematically constructs regulatory networks for pituitary tumours by integrating gene coexpression, transcriptional and posttranscriptional regulation. Through network analysis, we elaborate the incidence mechanism of pituitary adenoma. The Pearson's correlation coefficient was utilized to calculate the level of gene coexpression. By comparing pituitary adenoma samples with normal samples, pituitary adenoma-specific gene coexpression patterns were identified. For pituitary adenoma-specific coexpressed genes, we integrated transcription factor (TF) and microRNA (miRNA) regulation to construct a complex regulatory network from the transcriptional and posttranscriptional perspectives. Network module analysis identified the synergistic regulation of genes by miRNAs and TFs in pituitary adenoma. We identified 142 pituitary adenoma-specific active genes, including 43 TFs and 99 target genes of TFs. Functional enrichment of these 142 genes revealed that the occurrence of pituitary adenoma induced abnormalities in intracellular metabolism and angiogenesis process. These 142 genes were also significantly enriched in adenoma pathway. Module analysis of the systematic regulatory network found that three modules contained elements that were closely related to pituitary adenoma, such as FGF2 and SP1, as well as transcription factors and miRNAs involved in the tumourigenesis. These results show that in the occurrence of pituitary adenoma, miRNA, TF and genes interact with each other. Based on gene expression, the proposed method integrates interaction information from different levels and systematically explains the occurrence of pituitary tumours. It facilitates the tracing of the origin of the disease and can provide basis for early diagnosis of complex diseases or cancer without obvious symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24371170     DOI: 10.1007/s12041-013-0299-y

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  33 in total

1.  Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.

Authors:  Arianna Bottoni; Maria Chiara Zatelli; Manuela Ferracin; Federico Tagliati; Daniela Piccin; Cristina Vignali; George A Calin; Massimo Negrini; Carlo M Croce; Ettore C Degli Uberti
Journal:  J Cell Physiol       Date:  2007-02       Impact factor: 6.384

2.  Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.

Authors:  Takeshi Yamasaki; Hirofumi Yoshino; Hideki Enokida; Hideo Hidaka; Takeshi Chiyomaru; Nijiro Nohata; Takashi Kinoshita; Miki Fuse; Naohiko Seki; Masayuki Nakagawa
Journal:  Int J Oncol       Date:  2012-02-29       Impact factor: 5.650

Review 3.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

4.  Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas.

Authors:  Xian-Zeng Hou; Wei Liu; Hai-Tao Fan; Bin Liu; Bo Pang; Tao Xin; Shang-Chen Xu; Qi Pang
Journal:  Neuro Oncol       Date:  2010-03-03       Impact factor: 12.300

5.  Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas.

Authors:  Kyongsong Kim; Daizo Yoshida; Akira Teramoto
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.

Authors:  Cuiqi Zhou; Kolja Wawrowsky; Serguei Bannykh; Shiri Gutman; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-10-16

7.  A novel marine drug, SZ-685C, induces apoptosis of MMQ pituitary tumor cells by downregulating miR-200c.

Authors:  C-H Chen; W-W Xiao; X-B Jiang; J-W Wang; Z-G Mao; N Lei; X Fan; B-B Song; C-X Liao; H-J Wang; Z-G She; Y-H Zhu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Authors:  Naoto Kondo; Tatsuya Toyama; Hiroshi Sugiura; Yoshitaka Fujii; Hiroko Yamashita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

9.  Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.

Authors:  Hexin Chen; Ji Shin Lee; Xiaohui Liang; Huiping Zhang; Tao Zhu; Zhe Zhang; M Evangeline Taylor; Cynthia Zahnow; Lionel Feigenbaum; Alan Rein; Saraswati Sukumar
Journal:  Cancer Res       Date:  2008-05-07       Impact factor: 12.701

10.  Spindle cell oncocytoma of the adenohypophysis in a woman: a case report and review of the literature.

Authors:  M Mlika; H Azouz; I Chelly; I Ben Saïd; H Jemel; S Haouet; M Zitouna; N Kchir
Journal:  J Med Case Rep       Date:  2011-02-14
View more
  5 in total

Review 1.  Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.

Authors:  Jasjit K Banwait; Dhundy R Bastola
Journal:  Adv Drug Deliv Rev       Date:  2014-11-06       Impact factor: 15.470

2.  Regulatory networks in retinal ischemia-reperfusion injury.

Authors:  Kalina Andreeva; Maha M Soliman; Nigel G F Cooper
Journal:  BMC Genet       Date:  2015-04-24       Impact factor: 2.797

Review 3.  Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas.

Authors:  Ting Zhang; Zijiang Yang; Heng Gao
Journal:  J Neurooncol       Date:  2017-06-02       Impact factor: 4.130

4.  Correlations of ICAM-1 gene polymorphisms with susceptibility and multidrug resistance in colorectal cancer in a Chinese population.

Authors:  Lu-Bing Liu; Tong Liu; Fu-Ze Xin
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

5.  The role of galectin-3 in the tumorigenesis and progression of pituitary tumors.

Authors:  Bo Diao; Ying Liu; Guo-Zheng Xu; Yi Zhang; Jun Xie; Jie Gong
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.